DIMA BIOTECH
Dima Biotech is a tumor immunotherapy and monoclonal antibody developer, specializing in the development of recombinant monoclonal antibodies for tumor immune products and services. It has the unique RECmAb digital monoclonal antibody technology, which can be used to obtain a variety of genus and high quality. Monoclonal antibodies.
DIMA BIOTECH
Industry:
Biotechnology Health Care
Founded:
2019-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Total Employee:
11+
Status:
Active
Total Funding:
0
Investors List
ETP Ventures
ETP Ventures investment in Angel Round - Dima Biotech
Huatai Zijin Investment
Huatai Zijin Investment investment in Angel Round - Dima Biotech
Guoqian Venture Capital
Guoqian Venture Capital investment in Angel Round - Dima Biotech